Moreover, the intensity of inflammation is higher in patients with obstructive lung diseases in our study, especially observed for IL-6 in COPD and IL-8 in both asthma and COPD, and include other mediators e.g., TSLP and IL-33 in asthma. This evidence concerns the gene CXCL8 and asthma.